be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

Most popular

searches

All articles

Filters:

Tag: Non-Small Cell Lung Cancer

Show search box

2019-07-11

Pivotal announces participation in two clinical trials with a novel investigational immunot

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer

Pivotal, a specialist CRO, has been awarded two clinical trials for a novel investigational immunotherapy drug and patients' enrolment has now started. Pivotal will use its deep knowledge of oncology drug development to address a critical need for the expansion of immunotherapy programmes for Metasta... Read more

Tags clinical trials , pivotal , immunotherapy , Metastatic Melanoma , Non-Small Cell Lung Cancer